153 related articles for article (PubMed ID: 1710293)
1. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.
Fernie BF; Poli G; Fauci AS
J Virol; 1991 Jul; 65(7):3968-71. PubMed ID: 1710293
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
Smith MS; Thresher RJ; Pagano JS
Antimicrob Agents Chemother; 1991 Jan; 35(1):62-7. PubMed ID: 1707604
[TBL] [Abstract][Full Text] [Related]
4. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
5. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.
Biswas P; Poli G; Kinter AL; Justement JS; Stanley SK; Maury WJ; Bressler P; Orenstein JM; Fauci AS
J Exp Med; 1992 Sep; 176(3):739-50. PubMed ID: 1512539
[TBL] [Abstract][Full Text] [Related]
7. Anoxia induces human immunodeficiency virus expression in infected T cell lines.
Polonis VR; Anderson GR; Vahey MT; Morrow PJ; Stoler D; Redfield RR
J Biol Chem; 1991 Jun; 266(18):11421-4. PubMed ID: 1904863
[TBL] [Abstract][Full Text] [Related]
8. Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
Hansen BD; Nara PL; Maheshwari RK; Sidhu GS; Bernbaum JG; Hoekzema D; Meltzer MS; Gendelman HE
J Virol; 1992 Dec; 66(12):7543-8. PubMed ID: 1279206
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
Puddu P; Locardi C; Sestili P; Varano F; Petrini C; Modesti A; Masuelli L; Gresser I; Belardelli F
J Virol; 1991 May; 65(5):2245-53. PubMed ID: 1901915
[TBL] [Abstract][Full Text] [Related]
10. Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines.
Haynes JR; Cao SX; Rovinski B; Sia C; James O; Dekaban GA; Klein MH
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):17-27. PubMed ID: 1707639
[TBL] [Abstract][Full Text] [Related]
11. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
La Maestra L; Zaninoni A; Marriott JB; Lazzarin A; Dalgleish AG; Barcellini W
Clin Exp Immunol; 2000 Jan; 119(1):123-9. PubMed ID: 10606973
[TBL] [Abstract][Full Text] [Related]
12. Analysis of nonproductive human immunodeficiency virus type 1 infection of human fetal dorsal root ganglia glial cells.
Kunsch C; Wigdahl B
Intervirology; 1990; 31(2-4):147-58. PubMed ID: 1695619
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.
Cannon P; Kim SH; Ulich C; Kim S
J Virol; 1994 Mar; 68(3):1993-7. PubMed ID: 8107261
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
15. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
Buseyne F; McChesney M; Porrot F; Kovarik S; Guy B; Rivière Y
J Virol; 1993 Feb; 67(2):694-702. PubMed ID: 7678303
[TBL] [Abstract][Full Text] [Related]
16. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV).
Masquelier B; Combeau T; Poveda JD; Delord B; Pellegrin JL; Sallafranque-Andreola ML; Tarrago-Litvak L; Fleury HJ
J Acquir Immune Defic Syndr (1988); 1991; 4(5):499-505. PubMed ID: 1707962
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
Poli G; Kinter AL; Justement JS; Bressler P; Kehrl JH; Fauci AS
J Exp Med; 1991 Mar; 173(3):589-97. PubMed ID: 1705278
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
Okamoto M; Ono M; Baba M
AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907
[TBL] [Abstract][Full Text] [Related]
19. Modification of human immunodeficiency viral replication by pine cone extracts.
Lai PK; Donovan J; Takayama H; Sakagami H; Tanaka A; Konno K; Nonoyama M
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):205-17. PubMed ID: 1691654
[TBL] [Abstract][Full Text] [Related]
20. Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specific NF-kappa B binding proteins.
Vlach J; Pitha PM
Virology; 1992 Mar; 187(1):63-72. PubMed ID: 1371030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
